AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca core operating profit ($M) ($M)
Form 6-K Quarterly & Form 20-F Reported-to-Core Reconciliation
Latest, Q2 2026
5,158
Period ended Jun 30, 2026
Change on a year earlier
+12.5%
4,584 in Q2 2025
History
22 quarters
Since Q4 2020
Sources
22
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up core operating profit ($m)
- Core operating margin (% of total revenue)34.0% · Q2 2026
- Core operating profit YoY actual (%)12.0% · Q2 2026
- Core operating profit YoY CER (%)10.0% · Q2 2026
- Reported (IFRS) operating profit ($M)3,164 · Q2 2026
- Reported (IFRS) operating margin (%)21.0% · Q2 2026
- Core adjustment — Total restructuring charges ($M)-100 · Q2 2026
- Core adjustment — Intangible asset amortisation & impairments ($M)-1,546 · Q2 2026
Cite this data
StockData. (2026). AstraZeneca Core operating profit ($M) ($M), quarterly Q4 2020–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/core_op_profit
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.